Follow
T. Scior
T. Scior
Verified email at correo.buap.mx - Homepage
Title
Cited by
Cited by
Year
Recognizing pitfalls in virtual screening: a critical review
T Scior, A Bender, G Tresadern, JL Medina-Franco, K Martínez-Mayorga, ...
Journal of chemical information and modeling 52 (4), 867-881, 2012
4642012
Preliminary screening of some tropical plants for anti-tyrosinase activity
N Baurin, E Arnoult, T Scior, QT Do, P Bernard
Journal of ethnopharmacology 82 (2-3), 155-158, 2002
2542002
How to recognize and workaround pitfalls in QSAR studies: a critical review
T Scior, JL Medina-Franco, QT Do, K Martínez-Mayorga, JA Yunes Rojas, ...
Current medicinal chemistry 16 (32), 4297-4313, 2009
2392009
Adenosine receptors and their modulators
CE Müller, T Scior
Pharmaceutica Acta Helvetiae 68 (2), 77-111, 1993
1661993
Ethnopharmacology and bioinformatic combination for leads discovery: application to phospholipase A2 inhibitors
P Bernard, T Scior, B Didier, M Hibert, JY Berthon
Phytochemistry 58 (6), 865-874, 2001
1642001
Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors
SA Laufer, DM Domeyer, TRF Scior, W Albrecht, DRJ Hauser
Journal of medicinal chemistry 48 (3), 710-722, 2005
1312005
Isoniazid is not a lead compound for its pyridyl ring derivatives, isonicotinoyl amides, hydrazides, and hydrazones: a critical review
T Scior, SJ Garces-Eisele
Current medicinal chemistry 13 (18), 2205-2219, 2006
1062006
Why antidiabetic vanadium complexes are not in the pipeline of “big pharma” drug research? A critical review
T Scior, J Antonio Guevara-Garcia, QT Do, P Bernard, S Laufer
Current medicinal chemistry 23 (25), 2874-2891, 2016
1042016
Antitubercular Isoniazid and Drug Resistance of Mycobacterium tuberculosis — A Review
T Scior, I Meneses Morales, SJ Garcés Eisele, D Domeyer, S Laufer
Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2002
892002
Scaffold diversity analysis of compound data sets using an entropy‐based measure
JL Medina‐Franco, K Martínez‐Mayorga, A Bender, T Scior
QSAR & Combinatorial Science 28 (11‐12), 1551-1560, 2009
882009
Are vanadium compounds drugable? Structures and effects of antidiabetic vanadium compounds: a critical review
T Scior, A Guevara-García, P Bernard, QT Do, D Domeyer, S Laufer
Mini reviews in medicinal chemistry 5 (11), 995-1008, 2005
662005
Large compound databases for structure-activity relationships studies in drug discovery.
T Scior, P Bernard, JL Medina-Franco, GM Maggiora
Mini Reviews in Medicinal Chemistry 7 (8), 851-860, 2007
632007
Prolyl isomerases in a minimal cell: Catalysis of protein folding by trigger factor from Mycoplasma genitalium
H Bang, A Pecht, G Raddatz, T Scior, W Solbach, K Brune, A Pahl
European Journal of Biochemistry 267 (11), 3270-3280, 2000
462000
Antidiabetic Bis-Maltolato-OxoVanadium (IV): conversion of inactive trans-to bioactive cis-BMOV for possible binding to target PTP-1B
T Scior, HG Mack, JAG García, W Koch
Drug Design, Development and Therapy, 221-231, 2009
412009
Application of drug repositioning strategy to TOFISOPAM
P Bernard, C Dufresne-Favetta, P Favetta, QT Do, F Himbert, S Zubrzycki, ...
Current medicinal chemistry 15 (30), 3196-3203, 2008
412008
Reverse pharmacognosy: another way to harness the generosity of nature
S Blondeau, QT Do, T Scior, P Bernard, L Morin-Allory
Current pharmaceutical design 16 (15), 1682-1696, 2010
392010
Reviewing and identifying amino acids of human, murine, canine and equine TLR4/MD-2 receptor complexes conferring endotoxic innate immunity activation by LPS/lipid A, or …
T Scior, C Alexander, U Zaehringer
Computational and structural biotechnology journal 5 (6), e201302012, 2013
352013
11-keto-β-boswellic acids prevent development of autoimmune reactions, insulitis and reduce hyperglycemia during induction of multiple low-dose streptozotocin (MLD-STZ …
AM Shehata, L Quintanilla-Fend, S Bettio, J Jauch, T Scior, ...
Hormone and Metabolic Research 47 (06), 463-469, 2015
332015
Pharmacophore design of p38α MAP kinase inhibitors with either 2, 4, 5-trisubstituted or 1, 2, 4, 5-tetrasubstituted imidazole scaffold
T Scior, D M Domeyer, K Cuanalo-Contreras, S A Laufer
Current medicinal chemistry 18 (10), 1526-1539, 2011
332011
Elucidating isoniazid resistance using molecular modeling
HA Wahab, YS Choong, P Ibrahim, A Sadikun, T Scior
Journal of chemical information and modeling 49 (1), 97-107, 2009
302009
The system can't perform the operation now. Try again later.
Articles 1–20